Interferon-beta treatment for patients with multiple sclerosis: The patients' perceptions of the side-effects

Multiple Sclerosis

Volumn 6, Issue 5, 2000, Pages 349-354

  Gottberg, K ^a   Gardulf, A ^a,b   Fredrikson, S ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Interferon beta; Multiple sclerosis; Quality of life; Side effects; Symptom distress; Symptom occurrence

Indexed keywords

BETA1A INTERFERON; INTERFERON BETA SERINE; PARACETAMOL; RECOMBINANT BETA INTERFERON;

ADULT; AFFECTIVE NEUROSIS; ALOPECIA; ARTICLE; ASTHENIA; CENTRAL NERVOUS SYSTEM DISEASE; CLINICAL ARTICLE; CLINICAL SKIN REACTION; DAILY LIFE ACTIVITY; DYSPNEA; ERYTHEMA; FATIGUE; FEMALE; FLU LIKE SYNDROME; GASTROINTESTINAL DISEASE; HEART PALPITATION; HUMAN; INJECTION PAIN; INJECTION SITE; MALE; MENSTRUATION DISORDER; MULTIPLE SCLEROSIS; PATIENT ATTITUDE; PATIENT EDUCATION; QUALITY OF LIFE;

ACTIVITIES OF DAILY LIVING; ADJUVANTS, IMMUNOLOGIC; ADULT; FEMALE; HUMANS; INTERFERON-BETA; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; PATIENT EDUCATION; PATIENT SATISFACTION; QUALITY OF LIFE;

EID: 0033754825     PISSN: 13524585     EISSN: None     Source Type: Journal    
DOI: 10.1177/135245850000600510     Document Type: Article

References (21)

1. Interferon beta-1b is effective in relapsing/remitting multiple sclerosis. I. Clinical results of a multicenter, randomised, double-blind, placebo-controlled trial
2. Interferon beta-1b in the treatment of multiple sclerosis. Final outcome of the randomized controlled trial
3. Intramuscular interferon beta-1a for disease progression in relapsing multiple sclerosis
4. Management of patients receiving interferon beta 1b for multiple sclerosis. Report from a consensus conference
5. Managing side effects of interferon-beta in patients with relapsing-remitting multiple sclerosis
6. Multiple sclerosis. Side effects of interferon beta therapy and their management
7. Education and self-management of interferon beta-1b therapy for multiple sclerosis
8. Nursing management of MS patients receiving interferon beta-1b therapy
9. Development of a symptom distress scale
10. Home treatment of hypoglammaglobulinaemia with subcutaneous gammaglobulin by rapid infusion
11. Lifelong treatment with gammaglobulin for primary antibody deficiencies: The patients' experiences of subcutaneous self-infusions and home therapy
12. Subcutaneous immunoglobulin replacement in patients with primary antibody deficiencies: Safety and costs
13. Symptom management in multiple sclerosis
14. Mechanisms, measurements, and management of fatigue in multiple sclerosis
15. Depression as a major sympton of multiple sclerosis
16. Side-effect profile of interferon beta-1b in MS: Results of an open label trial
17. Side-effect profile and adherence to in the treatment of multiple sclerosis with interferon beta-1a
18. Placebo-controlled multicentre randomised trial of interferon β-1b in treatment of secondary progressive multiple sclerosis
19. Randomized double-blind placebo-controlled study of interferon-1a in relapsing/remitting multiple sclerosis
20. Interferon beta-1b injection site reactions and necrosis